Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Markers, Biological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04840771
What this trial is testing

Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery

Who this might be right for
Pituitary Adenoma
Federico II University 8
Not applicableUnknownNCT04549064
What this trial is testing

Biomarkers of Pancreatic Cancer and New Way to Detection

Who this might be right for
Pancreatic Cancer
First Affiliated Hospital Xi'an Jiaotong University 600
Testing effectiveness (Phase 2)WithdrawnNCT02263898
What this trial is testing

Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 Mutations

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT01339975
What this trial is testing

Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma

Who this might be right for
CarcinomaCarcinoma Renal CellKidney Neoplasms+2 more
University Hospital, Bordeaux 310
Not applicableEnded earlyNCT04698681
What this trial is testing

NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 20
Not applicableLooking for participantsNCT06305728
What this trial is testing

Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

Who this might be right for
Pancreatic Cyst
Memorial Sloan Kettering Cancer Center 25
Not applicableUnknownNCT05800236
What this trial is testing

Characterisation of the Intratumoral Microbiome in Gastric Adenocarcinoma: to a Personalised Medicine

Who this might be right for
Gastric Adenocarcinoma
University Hospital, Bordeaux 20
Testing effectiveness (Phase 2)Looking for participantsNCT07627711
What this trial is testing

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally AdvancedMetastatic Disease
Beijing Biotech 42
Very early researchEnded earlyNCT04930991
What this trial is testing

High Dose Omeprazole in Patients With Pancreatic Cancer

Who this might be right for
Exocrine Pancreatic Cancer
University of Oklahoma 25
Testing effectiveness (Phase 2)UnknownNCT00795171
What this trial is testing

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Medical University of Vienna 60
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Testing effectiveness (Phase 2)WithdrawnNCT04038489
What this trial is testing

COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast Cancer
University of Virginia
Not applicableUnknownNCT06153849
What this trial is testing

Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease Followup

Who this might be right for
Bladder Cancer
Changhai Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04957615
What this trial is testing

Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression

Who this might be right for
Metastatic Malignant Solid NeoplasmUnresectable Solid Neoplasm
M.D. Anderson Cancer Center 16
Post-approval studies (Phase 4)Study completedNCT03038152
What this trial is testing

Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery

Who this might be right for
Breast Carcinoma Metastatic in Lymph NodeStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7+3 more
M.D. Anderson Cancer Center 54
Not applicableUnknownNCT02749838
What this trial is testing

Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens

Who this might be right for
Cancer
Pharmatech 183
Not applicableLooking for participantsNCT06307314
What this trial is testing

Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis

Who this might be right for
Nasopharyngeal CarcinomaHead and Neck CancerRadiotherapy-induced Oral Mucositis+1 more
Nanfang Hospital, Southern Medical University 300
Not applicableActive Not RecruitingNCT04449406
What this trial is testing

Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Queen Mary University of London 3,500
Not applicableActive Not RecruitingNCT05612048
What this trial is testing

Tooth Erosion in People With Esophagogastric Cancer

Who this might be right for
Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center 174
Testing effectiveness (Phase 2)Study completedNCT01396655
What this trial is testing

PET in Breast Cancer Receiving Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Seoul National University Hospital 78
Next Page